Yuka Inoue

952 total citations
33 papers, 569 citations indexed

About

Yuka Inoue is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Yuka Inoue has authored 33 papers receiving a total of 569 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 12 papers in Molecular Biology and 8 papers in Cancer Research. Recurrent topics in Yuka Inoue's work include Cancer Immunotherapy and Biomarkers (5 papers), Immunotherapy and Immune Responses (5 papers) and Metastasis and carcinoma case studies (4 papers). Yuka Inoue is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Immunotherapy and Immune Responses (5 papers) and Metastasis and carcinoma case studies (4 papers). Yuka Inoue collaborates with scholars based in Japan, United States and Oman. Yuka Inoue's co-authors include Shoichi Hazama, Yoshihiko Maehara, Nami Yamashita, Eiji Oki, Eriko Tokunaga, Kimihiro Tanaka, Hiroshi Saeki, Hiroyuki Kitao, Ryouichi Tsunedomi and Masaaki Oka and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Science.

In The Last Decade

Yuka Inoue

30 papers receiving 565 citations

Peers

Yuka Inoue
Emily Pittman United States
Tae Sung Ahn South Korea
Rico D. Bense Netherlands
Yuka Inoue
Citations per year, relative to Yuka Inoue Yuka Inoue (= 1×) peers Chang-Long Chen

Countries citing papers authored by Yuka Inoue

Since Specialization
Citations

This map shows the geographic impact of Yuka Inoue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuka Inoue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuka Inoue more than expected).

Fields of papers citing papers by Yuka Inoue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuka Inoue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuka Inoue. The network helps show where Yuka Inoue may publish in the future.

Co-authorship network of co-authors of Yuka Inoue

This figure shows the co-authorship network connecting the top 25 collaborators of Yuka Inoue. A scholar is included among the top collaborators of Yuka Inoue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuka Inoue. Yuka Inoue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamashita, Nami, Eriko Tokunaga, Makoto Iimori, et al.. (2018). Epithelial Paradox: Clinical Significance of Coexpression of E-cadherin and Vimentin With Regard to Invasion and Metastasis of Breast Cancer. Clinical Breast Cancer. 18(5). e1003–e1009. 64 indexed citations
2.
Inoue, Yuka, Nami Yamashita, Hiroki Ueo, et al.. (2018). The Clinical Usefulness of the LigaSure™ Small Jaw in Axillary Lymph Node Dissection in Patients with Breast Cancer. Anticancer Research. 38(4). 2359–2362. 6 indexed citations
3.
Shoji, Fumihiro, Nami Yamashita, Yuka Inoue, et al.. (2017). Surgical Resection and Outcome of Synchronous and Metachronous Primary Lung Cancer in Breast Cancer Patients. Anticancer Research. 37(10). 5871–5876. 2 indexed citations
4.
Yamashita, Nami, Eriko Tokunaga, Hidetaka Yamamoto, et al.. (2017). The Local Recurrence of Breast Cancer with Squamous Metaplasia and Obvious Histological Heterogeneity. Anticancer Research. 37(9). 5249–5254.
5.
Yamamoto, Shigeru, Noriko Maeda, Yukiko Nagashima, et al.. (2017). A phase II, multicenter, single-arm study of tri-weekly low-dose nanoparticle albumin-bound paclitaxel chemotherapy for patients with metastatic or recurrent breast cancer. Breast Cancer. 24(6). 783–789. 11 indexed citations
6.
Inoue, Yuka, Nami Yamashita, Hiroyuki Kitao, et al.. (2017). Clinical Significance of the Wild Type p53-Induced Phosphatase 1 Expression in Invasive Breast Cancer. Clinical Breast Cancer. 18(4). e643–e650. 7 indexed citations
7.
Tamura, Kenji, Shoichi Hazama, Rui Yamaguchi, et al.. (2016). Characterization of the T cell repertoire by deep T cell receptor sequencing in tissues and blood from patients with advanced colorectal cancer. Oncology Letters. 11(6). 3643–3649. 34 indexed citations
8.
Hazama, Shoichi, Ryouichi Tsunedomi, Hironori Tanaka, et al.. (2016). MicroRNA-6826 and −6875 in plasma are valuable non-invasive biomarkers that predict the efficacy of vaccine treatment against metastatic colorectal cancer. Oncology Reports. 37(1). 23–30. 33 indexed citations
9.
Tanaka, Kimihiro, Eriko Tokunaga, Yuka Inoue, et al.. (2016). Impact of Expression of Vimentin and Axl in Breast Cancer. Clinical Breast Cancer. 16(6). 520–526.e2. 37 indexed citations
10.
Hazama, Shoichi, Ryouichi Tsunedomi, Hiroko Takenouchi, et al.. (2016). Prediction of the efficacy of immunotherapy by measuring the integrity of cell‐free DNA in plasma in colorectal cancer. Cancer Science. 107(12). 1825–1829. 23 indexed citations
11.
Tokunaga, Eriko, Nami Yamashita, Hiroyuki Kitao, et al.. (2015). Biological and clinical significance of loss of heterozygosity at the INPP4B gene locus in Japanese breast cancer. The Breast. 25. 62–68. 6 indexed citations
12.
Yamashita, Nami, Eriko Tokunaga, Hiroyuki Kitao, et al.. (2015). Epigenetic Inactivation of BRCA1 Through Promoter Hypermethylation and Its Clinical Importance in Triple-Negative Breast Cancer. Clinical Breast Cancer. 15(6). 498–504. 43 indexed citations
13.
Takami, Yoichiro, K. Moriyama, Yuka Inoue, et al.. (2015). Prevention of the exposure by cyclophosphamide oral tablet. Journal of Pharmaceutical Health Care and Sciences. 1(1). 20–20. 5 indexed citations
14.
Tsunedomi, Ryouichi, Shoichi Hazama, Yusuke Fujita, et al.. (2014). A novel system for predicting the toxicity of irinotecan based on statistical pattern recognition with UGT1A genotypes. International Journal of Oncology. 45(4). 1381–1390. 13 indexed citations
15.
Inoue, Yuka, Shoichi Hazama, Shigeyoshi Iwamoto, et al.. (2014). FcγR and EGFR Polymorphisms as Predictive Markers of Cetuximab Efficacy in Metastatic Colorectal Cancer. Molecular Diagnosis & Therapy. 18(5). 541–548. 9 indexed citations
16.
Hazama, Shoichi, Yusuke Nakamura, Hiroko Takenouchi, et al.. (2014). A phase I study of combination vaccine treatment of five therapeutic epitope-peptides for metastatic colorectal cancer; safety, immunological response, and clinical outcome. Journal of Translational Medicine. 12(1). 63–63. 66 indexed citations
17.
Hazama, Shoichi, Hideyuki Mishima, Ryouichi Tsunedomi, et al.. (2013). UGT1A1*6,1A7*3, and 1A9*22 genotypes predict severe neutropenia in FOLFIRI‐treated metastatic colorectal cancer in two prospective studies in Japan. Cancer Science. 104(12). 1662–1669. 27 indexed citations
18.
Takahashi, Hiroki, Teruhiko Fujii, Shino Nakagawa, et al.. (2013). Usefulness of endoscopic breast-conserving surgery for breast cancer. Surgery Today. 44(11). 2037–2044. 18 indexed citations
19.
Matsubayashi, Roka Namoto, Yuka Inoue, Seiichi Okamura, et al.. (2013). MR imaging of malignant primary breast lymphoma: including diffusion-weighted imaging, histologic features, and a literature review. Japanese Journal of Radiology. 31(10). 668–676. 10 indexed citations
20.
Takahashi, Hiroki, et al.. (2009). A CASE OF A RAPIDLY WORSENING MALIGNANT PHYLLODES TUMOR WITH AXILLARY LYMPH NODE METASTASIS. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 70(1). 39–43.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026